Home Compare MDT vs ZBH
Stock Comparison · Industry comparison · Medical Devices

Medtronic vs Zimmer Biomet Holdings: Which Stock Looks Stronger in 2026?

Medtronic holds the cleaner structural position, with stability as the main driver and profitability adding further support. Zimmer Biomet does not offset that deficit through any equally strong structural edge elsewhere. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in stability, but profitability adds another real layer to the result. The overall score gap is 15 points in favour of Medtronic plc.

INDUSTRY COMPARISON

Both operate in: Medical Devices

This comparison is based on industry proximity, not on functional trajectory similarity. MDT and ZBH share the same industry classification.

For a similarity-based comparison, see how Medtronic and Zimmer Biomet each position within their functional peer groups in AssetNext.

Peer-Relative Score
MDT
Medtronic plc
51
Peer-Score
Signal qualityHigh
vs
ZBH
Zimmer Biomet Holdings, Inc.
36
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: MDT vs ZBH Profitability 24 0 Stability 72 41 Valuation 74 70 Growth 33 33 MDT ZBH
Gap Ranking
#1 Stability +31
#2 Profitability +24
#3 Valuation +4
#4 Growth
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for MDT and ZBH Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer MDTZBH Relative valuation Structural strength

Neither company combines the stronger profile with the cheaper valuation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Both rank well on stability, but Medtronic plc still holds a clear edge.
Profitability
Neither side looks especially strong on profitability, though Medtronic plc still ranks somewhat higher.
Stability — Dominant Gap
MDT
72
ZBH
41
Gap+31in favour of MDT

The stability gap is wide, with the stronger side looking materially steadier through time.

What else supports the lead

Profitability reinforces the lead rather than leaving the result tied to one dimension, with a 6-point operating margin advantage.

What this means for the comparison

Stability is the clearest driver, and profitability also supports Medtronic plc's broader structural position.

Explore full peer positioning in AssetNext

Break down the MDT vs ZBH comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar stability-and-profitability comparisons

Explore how MDT and ZBH each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.